CYTOKINETICS, INCORPORATED |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 49.1 EUR | -1.80% |
|
+2.89% | -32.70% |
| 01:30pm | Cytokinetics Announces Initiation of Phase 1 Study of Aficamten in Healthy Japanese Participants | CI |
| 06-11 | Cytokinetics Insider Sold Shares Worth $413,106, According to a Recent SEC Filing | MT |
3a560ac35daf61d68cba9b21166.WtQMNNQOgu4RzjPYH8VsNkBpLzXBNYtEO3_w38YVniU.K7pHZr830d1ZvUqXd5YAYCUdQnGGV910VS2hi_5Sx2wz-T5-4X63vEGWag~3bcff772d50c125fd60eeacb10ab8a84
